Moderna cancer vaccine holds up; IO Biotech considers a sale
Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, Insilico Medicine partnered with a startup on a popular drug target. Continue reading →
Expert Insight on Under Armour’s Exposed Customer Data
72 million emails have been exposed. Continue reading →
Corvus shares nearly triple on positive data for eczema pill
While early, the results indicate drugs known as ITK inhibitors have the potential to match or surpass the efficacy observed with the injectable biologic Dupixent. Continue reading →
Lemaire Fall 2026: All the World’s a Stage
The lineup telegraphed Lemaire-typical sensuality but details felt lost in motion. Continue reading →
Make Us Swoon: Send In Your Health Policy Valentines
Affordable health care is our love language. Stoke the fire by submitting your sweetest “Health Policy Valentines.” We want to see your clever, heartfelt, or hilarious tributes to the policies that shape health care. An esteemed panel of editors will review entries. We’ll share...
Sportmax Pre-Fall 2026: On the Move
Travel dressing and packing solutions informed the pragmatic approach the Sportmax design team adopted this season. Continue reading →
Giambattista Valli Cancels Haute Couture Show
The display, scheduled for Jan. 26 during Paris Couture Week, will not go on as “the maison is currently engaged in a thorough reflection.” Continue reading →
4 education legal and policy trends to watch in 2026
From civic education advocacy to religious public schools, here’s what K-12 leaders can expect in the legal and policy spheres. Continue reading →
As student enrollment declines, a look at public school closures
We’re tracking districts’ plans to shutter or consolidate schools amid enrollment pressure from falling birthrates and growing school choice. Continue reading →